Tumor-specific T-cell-induced IFNγ can induce lethal anti-tumor immunity by promoting tumor antigen presentation, recruiting of other immune cells, and directing anti-proliferative and pro-apoptotic effects toward the tumor cells [35,36]. The gene discussed is IFNG; the disease is neoplasm.